United States · Funded startup

Who invested in Aeglea BioTherapeutics

3 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$266Mraised across 3 rounds since 2014, from 3 sources

$12MSeries A$44MSeries B$210MRound
Latest round
Round, $210MJun 2023
Step-upi
4.8×
Investors
10
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20142016201820202022
$12MSeries A$44MSeries B$210MRound
First round
Series A, $12M
Jan 2014
Biggest round
$210M
Round · Jun 2023
Usual gap between rounds
8.2 years
the median of 2

The rounds

  1. Jun 2023
    Round$210M2 new1 returning

    Source recordedSEC filing: $210M sold, first sale Jun 2023

  2. Mar 2015
    Series B$44M2 new3 returning

    From a historical funding recordSEC filing: $44M sold, first sale Mar 2015

  3. Jan 2014
    Series A$12M6 new

    From a historical funding recordSEC filing: $5.1M sold, first sale Dec 2013

Founders and team

From the SEC filings it signed: 3 on the team.

  • Cameron TurtleExecutive Officeri
  • Cortney CaudillExecutive Officeri
  • Jonathan AlspaughExecutive Officeri

On the board, as filediAlison J. LawtonHunter CIvana J. Magovcevic-LiebischMichael J. HendersonPeter J. HarwinRussell J. CoxTomas J. Kiselak

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

VenrockVC firm2rounds
Novartis Venture FundCorporate VC2rounds
Lilly VenturesGrowth equity2rounds
UT Horizon FundVC firm2rounds
OrbiMedPrivate equity1round
RA Capital ManagementPrivate equity1round
New Ground VenturesVC firm1round
KBI BiopharmaCorporate VC1round
ATX Tech Incubatorno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Aeglea BioTherapeutics

Who invested in Aeglea BioTherapeutics?

Aeglea BioTherapeutics's investors include Venrock, Novartis Venture Fund, Lilly Ventures, UT Horizon Fund and OrbiMed, and 5 more on record.

How much has Aeglea BioTherapeutics raised?

Aeglea BioTherapeutics has raised $266M across 3 rounds since 2014.

When did Aeglea BioTherapeutics last raise?

Aeglea BioTherapeutics's most recent round was an Undisclosed round of $210M in Jun 2023.

What was Aeglea BioTherapeutics's biggest round?

Its most recent round, $210M in Jun 2023, is also its largest on record.

Who backed Aeglea BioTherapeutics first?

Aeglea BioTherapeutics's first round on record, in Jan 2014, was backed by Novartis Venture Fund, Lilly Ventures and UT Horizon Fund and 3 others.

What stage is Aeglea BioTherapeutics at?

Aeglea BioTherapeutics's latest named round is an Undisclosed round, in Jun 2023.

Where is Aeglea BioTherapeutics based?

Aeglea BioTherapeutics is based in the United States.

Companies like Aeglea BioTherapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.